KaloBios Pharmaceuticals, Inc. (NASDAQ:KBIO) presented at the 26th Annual ROTH Conference on Wednesday, March 12, 2014 in Laguna Niguel, Californi 8:00 – 8:30 AM. Pacific Time KaloBios Pharmaceuticals Inc (NASDAQ:KBIO) stock performance was -5.03% in last session and finished the day at $3.02. Traded volume was 205,759.00million shares in the last session and the average volume of the stock remained 355.36K shares. KaloBios Pharmaceuticals Inc … Continue reading Drug Manufacturer Most Volatile: KaloBios Pharmaceuticals Inc (NASDAQ:KBIO), Zogenix (NASDAQ:ZGNX), Rigel Pharmaceuticals (NASDAQ:RIGL), GW Pharmaceuticals (NASDAQ:GWPH)